Compagnie Lombard Odier S Cm A Viatris Inc Transaction History

Compagnie Lombard Odier S Cm A

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$10.05 - $12.02 $231 - $276	-23 Reduced 0.44%	5,206 $55,000
Q1 2023 May 01, 2023	SELL	$9.2 - $12.26 $2,962 - $3,947	-322 Reduced 5.8%	5,229 $50,000
Q3 2022 Nov 09, 2022	SELL	$8.48 - $11.13 $1,051 - $1,380	-124 Reduced 2.19%	5,551 $49,000
Q1 2022 Apr 27, 2022	SELL	$9.81 - $15.4 $3,561 - $5,590	-363 Reduced 6.01%	5,675 $62,000
Q3 2021 Oct 28, 2021	SELL	$13.25 - $15.13 $81,673 - $93,261	-6,164 Reduced 50.52%	6,038 $83,000
Q2 2021 Jul 15, 2021	BUY	$12.97 - $16.15 $41,166 - $51,260	3,174 Added 35.16%	12,202 $175,000
Q1 2021 Apr 23, 2021	SELL	$13.59 - $18.54 $53,218 - $72,602	-3,916 Reduced 30.25%	9,028 $127,000
Q4 2020 Feb 09, 2021	BUY	$14.3 - $18.74 $185,099 - $242,570	12,944 New	12,944 $244,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.